Undiagnosed Hemoglobinopathies: A potential threat to the premarital screening program.

Premarital screening hemoglobinopathy sickle cell anemia thalassemia

Journal

Pakistan journal of medical sciences
ISSN: 1682-024X
Titre abrégé: Pak J Med Sci
Pays: Pakistan
ID NLM: 100913117

Informations de publication

Date de publication:
Historique:
entrez: 29 11 2019
pubmed: 30 11 2019
medline: 30 11 2019
Statut: ppublish

Résumé

To evaluate the prevalence of undiagnosed hemoglobinopathies among individuals visiting the premarital screening Centre. This study was conducted at Premarital Screening Centre, King Fahad Central Hospital and Research Centre, Jazan, between January 2018 and October 2018. A total of 3,970 (male n =1,859 and female n = 2,111) individuals were included in the study. Data of complete blood count, hemoglobin electrophoresis and sickling tests of all individuals recruited in the study were obtained and statistically analyzed. One thousand three hundred and twelve individuals had abnormal complete blood counts or hemoglobin electrophoresis results, that include sickle cell trait (13.5%), sickle cell disease (0.7%), β thalassemia with sickle cell trait (2.46%), β thalassemia trait (1.51%), β thalassemia major (0.075%), suspected α thalassemia or other hemoglobinopathies (4.43%), hemoglobin H (0.3%), hemoglobin E (0.075%), undiagnosed cases (0.91%) and iron deficient (7.23%). A high percentage of individuals are suspected for α thalassemia or other hemoglobinopathies that needs to be diagnosed. Further investigations shall be included in the premarital screening program to diagnose these inconclusive cases. Coexistence iron deficiency with thalassemia shall also be ruled out during premarital screening program.

Identifiants

pubmed: 31777502
doi: 10.12669/pjms.35.6.976
pii: PJMS-35-1611
pmc: PMC6861477
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1611-1615

Informations de copyright

Copyright: © Pakistan Journal of Medical Sciences.

Références

Genet Med. 2007 Jun;9(6):372-7
pubmed: 17575503
BMJ. 2006 Oct 21;333(7573):831-4
pubmed: 17053236
J Epidemiol Glob Health. 2011 Dec;1(1):61-8
pubmed: 23856375
J Med Screen. 2009;16(1):22-8
pubmed: 19349527
J Epidemiol Glob Health. 2018 Mar;7 Suppl 1:S41-S47
pubmed: 29801592
Public Health Genomics. 2015;18(4):193-203
pubmed: 26045079
Braz J Med Biol Res. 2001 Jun;34(6):759-62
pubmed: 11378664
ISRN Hematol. 2014 Mar 12;2014:293216
pubmed: 25006473
Genet Test Mol Biomarkers. 2012 Jan;16(1):25-9
pubmed: 21861712
Saudi Med J. 2000 Jul;21(7):666-71
pubmed: 11500731
Ann Saudi Med. 2006 Jan-Feb;26(1):14-6
pubmed: 16521869
Prenat Diagn. 2010 May;30(5):478-81
pubmed: 20440737
Korean J Hematol. 2011 Mar;46(1):41-4
pubmed: 21461303
Mediterr J Hematol Infect Dis. 2015 Jan 01;7(1):e2015004
pubmed: 25574363
Int J Lab Hematol. 2015 Feb;37(1):105-11
pubmed: 24754744

Auteurs

Hassan A Hamali (HA)

Hassan A. Hamali, Ph.D, Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.

Muhammad Saboor (M)

Muhammad Saboor, Ph.D, Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.

Classifications MeSH